69.07USD-4.69%Mkt Cap: 26.65B $P/E: 29.641d ago
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States an…
Indicators:|
Key Statistics
Company
Market Cap26.65B $
Enterprise Value26.93B $
Revenue (TTM)4.82B $
Gross Profit2.80B $
Net Income (TTM)836.30M $
Revenue/Share12.39 USD
Last Price69.07 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS2521311074
Valuation
P/E (Trailing)29.64
P/E (Forward)23.51
PEG1.35
EV/EBITDA20.84
EV/Revenue5.59
P/S5.80
P/B9.46
EPS (TTM)2.33
EPS (Forward)3.08
52W Range
54.1142% of range89.98
52W High89.98 USD
52W Low54.11 USD
Profitability
Gross Margin60.10%
Oper. Margin21.42%
EBITDA Margin26.82%
Profit Margin17.94%
ROE30.46%
ROA13.19%
Growth
Revenue Growth15.00%
Earnings Growth92.20%
Cash Flow & Leverage
Operating CF1.44B $
CapEx (TTM)363.50M $
FCF Margin21.93%
FCF Yield3.96%
Net Debt-1.03B $
Net Debt/EBITDA-0.80
Balance Sheet
Debt/Equity0.51
Current Ratio1.95
Quick Ratio1.58
Book Value/Sh7.662 USD
Cash/Share6.259 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split4:1
Split DateJun 13, 2022
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)85.21 USD
Upside (mean)+23.4%
Target Range65.00 USD – 112.00 USD
$65.00+23.4% to mean$112.00
# Analysts24
Ownership
Shares Out.385.87M
Float384.50M
Insiders0.28%
Institutions102.47%
Short Interest
Short Ratio2.4d
Short % Float5.19%
Short % Out.4.51%
Shares Short17.39M
Short (prev mo.)18.32M
Technical
SMA 5066.60 (+3.7%)
SMA 20067.52 (+2.3%)
Beta1.44
S&P 52W Chg24.49%
Avg Vol (30d)5.81M
Avg Vol (10d)5.57M
Technical Indicators
RSI (14)45.1
MACD1.4580
MACD Signal2.3567
MACD Hist.-0.8986
BB Upper77.64 USD
BB Middle73.46 USD
BB Lower69.27 USD
BB Width11.40%
ATR (14)2.848 USD
Vol Ratio (20d)0.94x